-
Pipeline or wipeout? The antibiotic era is at risk; Childs play: Finding Bacillus on Barney; Prepare your facility for influenza season.
-
JCAHO lobbies for sign-off on patient safety law; Measles hits record low, imported cases remain; Public comment sought on CDC vaccine safety efforts.
-
Sources of funding for pharmaceutical research has come under scrutiny in the last decade as academic and government sources of funding have become increasingly scarce and the pharmaceutical industry has become the main source of research dollars. But the issue of objectivity has been raised, and some have even suggested that negative studies, that is studies that show a drug in an unfavorable light, may never be published. The American Medical Association has recently tackled this issue and has asked the department of Health and Human Services to establish a public registry of all clinical trials in United States.
-
End-stage renal disease is a devastating condition that, according to the United States Renal Data System, plagued approximately 406,000 individuals in the United States in 2001 and is projected to increase to a prevalence of approximately 725,000 by 2010. Furthermore, it is a major public health issue, given the overall poor outcomes and high costs for this chronic condition.
-
-
Federal health officials have recommended that the 2004-05 trivalent influenza vaccine for the United States contain A/New Caledonia/20/99-like (H1N1), A/Fujian/411/2002-like (H3N2), and B/Shanghai/361/2002-like viruses.
-
The Joint Commission is adding a new infection control standard for health care facilities that requires them to prepare for an influx of infectious patients. As part of emergency management activities, institutions must prepare for such an influx or the risk of an influx effective Jan. 1, 2005.
-
The following questions were among those asked during two recent surveys by the Joint Commission. The questions do not represent any kind of official survey, but were simply noted anecdotally by two infection control professionals as the questions were asked to them and other staff members.
-
Be proactive and get ready for an onslaught of questions from critical inquiries to the out-of-the-blue variety if youre preparing for a visit from the Joint Commission on Accreditation of Healthcare Organizations, advise two infection control professionals who recently went through the process.
-
A recent article by investigators at the Centers for Disease Control and Prevention (CDC) reiterated the following basic infection control measures to prevent patient-to-patient transmission of bloodborne pathogens in ambulatory care settings.
